Tareck Ayad

ORCID: 0000-0003-3673-7875
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Tracheal and airway disorders
  • Reconstructive Surgery and Microvascular Techniques
  • Dysphagia Assessment and Management
  • Salivary Gland Tumors Diagnosis and Treatment
  • Reconstructive Facial Surgery Techniques
  • Voice and Speech Disorders
  • Surgical Simulation and Training
  • Cleft Lip and Palate Research
  • Ear and Head Tumors
  • Airway Management and Intubation Techniques
  • Innovations in Medical Education
  • Olfactory and Sensory Function Studies
  • COVID-19 and healthcare impacts
  • Gastroesophageal reflux and treatments
  • Facial Nerve Paralysis Treatment and Research
  • Cancer Diagnosis and Treatment
  • Cancer-related molecular mechanisms research
  • Oral and Maxillofacial Pathology
  • Bone Tumor Diagnosis and Treatments
  • Long-Term Effects of COVID-19
  • Head and Neck Anomalies
  • Surgical site infection prevention
  • Respiratory and Cough-Related Research

Centre Hospitalier de l’Université de Montréal
2016-2025

Université de Montréal
2014-2025

Hôpital Maisonneuve-Rosemont
2014-2025

Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal
2024

Montreal General Hospital
2023

Aix-Marseille Université
2023

Johnson & Johnson (United States)
2021

McGill University
2021

Centre Hospitalier Universitaire Sainte-Justine
2020-2021

Louisiana State University
2018

The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway has previously been demonstrated in metastatic head and neck squamous cell carcinoma (HNSCC). Stereotactic Body Radiotherapy (SBRT) aims at ablating lesions may play a synergistic role with immunotherapy. purpose this study is to assess safety triple treatment combination (TTC) consisting administration durvalumab tremelimumab SBRT HNSCC. This phase I/II single arm that will include 35 patients 2–10 extracranial lesions. Patients...

10.1186/s12885-019-5266-4 article EN cc-by BMC Cancer 2019-01-14

Oral cavity cancer often requires multidisciplinary management, subjecting patients to complex therapeutic trajectories. Prolonged treatment intervals in oral have been associated with poor oncological outcomes, but there has yet be a study investigating times Canada.

10.1001/jamaoto.2023.1936 article EN JAMA Otolaryngology–Head & Neck Surgery 2023-07-09

Abstract Background. The purpose of this study is to review our experience with the use facial artery musculo‐mucosal (FAMM) flap for floor mouth (FOM) reconstruction following cancer ablation assess its reliability, associated complications, and functional results. Methods. This was a retrospective analysis 61 FAMM flaps performed FOM from 1997 2006. Results. No total loss observed. Fifteen cases partial necrosis occurred, 2 them requiring revision surgery. We encountered 8 other 4 surgery...

10.1002/hed.20722 article EN Head & Neck 2007-10-30

Importance The standard of care for patients with oral cavity squamous cell carcinoma (OCSCC) is generally primary surgical resection or without adjuvant therapy (AT), based on pathological factors. Identifying preoperative factors that are associated the receipt AT may enhance treatment planning. Objective To identify patient and tumor receiving AT, either radiation (RT) chemoradiation (CRT), in OCSCC. Design, Setting, Participants This cohort study, spanning January 2005 to December 2019...

10.1001/jamaoto.2024.5250 article EN JAMA Otolaryngology–Head & Neck Surgery 2025-03-27

Many nerve injuries have been associated with Eagle syndrome. The cranial nerves V, VII, IX, and X reported to be injured by the elongated styloid process in this syndrome.We describe a case of syndrome atypical symptoms hypoglossal palsy Horner syndrome.A 56-year-old woman presented right palsy, syndrome, neck pain, mimicking transient cerebral ischemia. An angioscan showed bilaterally compressing carotid artery causing 75% stenosis. After an en bloc resection process, there were no further...

10.1002/hed.23675 article EN Head & Neck 2014-03-11
Coming Soon ...